The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...

因为这颠覆了美国创新药市场，延续数十年的“高定价-长周期”商业模式。医保支付方与制药巨头的力量天平开始倾斜。而对于那些依赖单一爆品支撑的药企，正被迫在创新效率和成本控制间走钢丝。

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

4Q23 results included charges related to the Daiichi Sankyo collaboration .

Patient organisations have been celebrating the FDA approval yesterday of Amylyx' amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that ...

Global Diabetes Drug Market growth is driven by the rising incidence of diabetes and increasing adoption of innovative treatment solutions.Austin, United States, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ...

Januvia medication, tell her to ask her doctor to switch this diabetes medication to Tradjenta. The ...